Globus Medical Ownership
| GMED Stock | USD 73.34 1.75 2.44% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Globus |
Globus Stock Ownership Analysis
About 82.0% of the company shares are owned by institutional investors. The book value of Globus Medical was currently reported as 30.4. The company has Price/Earnings To Growth (PEG) ratio of 1.91. Globus Medical had not issued any dividends in recent years. Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. Globus Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 2400 people. To learn more about Globus Medical call David Paul at 610 930 1800 or check out https://www.globusmedical.com.Globus Medical Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Globus Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Globus Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Globus Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Keith Pfeil over two months ago Acquisition by Keith Pfeil of 5833 shares of Globus Medical at 49.65 subject to Rule 16b-3 | ||
Daniel Scavilla over two months ago Acquisition by Daniel Scavilla of 30000 shares of Globus Medical at 26.27 subject to Rule 16b-3 | ||
Kelly Huller over three months ago Acquisition by Kelly Huller of 40000 shares of Globus Medical at 53.75 subject to Rule 16b-3 | ||
Daniel Scavilla over six months ago Acquisition by Daniel Scavilla of 60000 shares of Globus Medical subject to Rule 16b-3 | ||
James Tobin over a year ago Acquisition by James Tobin of 15000 shares of Globus Medical subject to Rule 16b-3 | ||
Wolterman Dan over a year ago Acquisition by Wolterman Dan of 24025 shares of Globus Medical subject to Rule 16b-3 | ||
James Tobin over a year ago Acquisition by James Tobin of 15000 shares of Globus Medical subject to Rule 16b-3 |
Globus Medical Outstanding Bonds
Globus Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Globus Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Globus bonds can be classified according to their maturity, which is the date when Globus Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| GLOBAL PARTNERS LP Corp BondUS37954FAG90 | View | |
| US37954FAJ30 Corp BondUS37954FAJ30 | View | |
| US37959EAA01 Corp BondUS37959EAA01 | View | |
| GL 48 15 JUN 32 Corp BondUS37959EAB83 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.